Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017

  • ID: 4384337
  • Report
  • 111 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Akers Biosciences Inc
  • Alere Inc
  • Biocartis SA
  • Biosurfit, SA
  • Cepheid
  • ChipCare Corp
  • MORE
Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017

Summary

The author's Medical Devices sector report, “Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017" provides an overview of Hepatitis Viruses Rapid Tests & POC (Point Of Care) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Viruses Rapid Tests & POC (Point Of Care) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hepatitis Viruses Rapid Tests & POC (Point Of Care) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hepatitis Viruses Rapid Tests & POC (Point Of Care) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hepatitis Viruses Rapid Tests & POC (Point Of Care) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Akers Biosciences Inc
  • Alere Inc
  • Biocartis SA
  • Biosurfit, SA
  • Cepheid
  • ChipCare Corp
  • MORE
1 Table of Contents
2 Introduction
2.1 Hepatitis Viruses Rapid Tests & POC (Point Of Care) Overview
3 Products under Development
3.1 Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Stage of Development
3.2 Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Territory
3.3 Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Regulatory Path
3.4 Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Estimated Approval Date
4 Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products under Development by Companies
4.1 Hepatitis Viruses Rapid Tests & POC (Point Of Care) Companies - Pipeline Products by Stage of Development
4.2 Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Stage of Development
5 Hepatitis Viruses Rapid Tests & POC (Point Of Care) Companies and Product Overview
5.1 Akers Biosciences Inc Company Overview
5.1.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Alere Inc Company Overview
5.2.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Atomo Diagnostics Pty Limited Company Overview
5.3.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
5.4 Biocartis SA Company Overview
5.4.1 Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
5.5 bioLytical Laboratories Inc Company Overview
5.5.1 bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Biosurfit, SA Company Overview
5.6.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
5.7 Biotech Consortium India Ltd Company Overview
5.7.1 Biotech Consortium India Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Cepheid Company Overview
5.8.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview
5.9 Chembio Diagnostic Systems Inc Company Overview
5.9.1 Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 ChipCare Corp Company Overview
5.10.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
5.11 Co-Diagnostics HBDC, Inc. Company Overview
5.11.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.12 Correlia Biosystems, Inc. Company Overview
5.12.1 Correlia Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Daktari Diagnostics, Inc. Company Overview
5.13.1 Daktari Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Diagnostics For All Company Overview
5.14.1 Diagnostics For All Pipeline Products & Ongoing Clinical Trials Overview
5.15 Fast-track diagnostics S.a.r.l. Company Overview
5.15.1 Fast-track diagnostics S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview
5.16 GeneBio Systems Inc Company Overview
5.16.1 GeneBio Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 genedrive plc Company Overview
5.17.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Group K Diagnostics Company Overview
5.18.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.19 ImmunoScience Inc Company Overview
5.19.1 ImmunoScience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 MedMira Inc. Company Overview
5.20.1 MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.21 Micronics Inc Company Overview
5.21.1 Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Molbio Diagnostics Pvt. Ltd. Company Overview
5.22.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.23 NOWDiagnostics Company Overview
5.23.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.24 OPKO Health Inc Company Overview
5.24.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Sedia Biosciences Corp Company Overview
5.25.1 Sedia Biosciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.26 University of California Irvine Company Overview
5.26.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
5.27 Wave 80 Biosciences Inc Company Overview
5.27.1 Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Xagenic Inc. Company Overview
5.28.1 Xagenic Inc. Pipeline Products & Ongoing Clinical Trials Overview
6 Hepatitis Viruses Rapid Tests & POC (Point Of Care)- Recent Developments
6.1 Aug 08, 2017: Akers Biosciences Announces Board Changes
6.2 Aug 07, 2017: Quotient Reports Results From Ongoing MosaiQ Performance Evaluation Studies and First Quarter Fiscal 2018 Financial Results
6.3 Aug 03, 2017: Akers Biosciences Announces Second Quarter Trading Update
6.4 Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results
6.5 Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin
6.6 May 22, 2017: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results
6.7 May 16, 2017: NOWDiagnostics CEO Kevin Clark to Address Technology Conference
6.8 May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings
6.9 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results
6.10 Apr 24, 2017: Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility
6.11 Apr 11, 2017: Genedrive Announces Hepatitis C Assay performance data accepted for presentation at the International Liver Confrence , April 19-23 in Amsterdam
6.12 Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016
6.13 Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016
6.14 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors
6.15 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency
6.16 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal
6.17 Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016
6.18 Mar 30, 2017: Genedrive: Interim Results for the six month period to 31 December 2016
6.19 Mar 27, 2017: Genedrive HCV Assay Submitted For CE IVD Certification
6.20 Mar 08, 2017: genedrive Announces Successful Clinical Results for Genedrive HCV Assay
6.21 Feb 09, 2017: Quotient Announces Appointment of Christopher Lindop as Chief Financial Officer
6.22 Feb 06, 2017: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Third Quarter Fiscal 2017 Financial Results
6.23 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results
6.24 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration
6.25 Nov 29, 2016: genedrive: Update on CFO Appointment
6.26 Nov 14, 2016: Akers Biosciences Announces Q3 Earnings
6.27 Nov 02, 2016: Quotient Announces CFO Transition
6.28 Oct 31, 2016: Quotient Second Quarter Fiscal 2017 Financial Results
6.29 Oct 31, 2016: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Second Quarter Fiscal 2017 Financial Results
6.30 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results
6.31 Oct 11, 2016: Genedrive Announces Preliminary Results for the year ended 30 June 2016
6.32 Sep 30, 2016: Correlia Bio Receives NIH SBIR Grant to Develop Diagnostic Test For Hepatitis C Infection
6.33 Sep 21, 2016: Genedrive Announces Appointment of Chief Financial Officer
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Stage of Development
Table 2: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Territory
Table 3: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Regulatory Path
Table 4: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Estimated Approval Date
Table 5: Hepatitis Viruses Rapid Tests & POC (Point Of Care) Companies - Pipeline Products by Stage of Development
Table 6: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Stage of Development
Table 7: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 8: PIFA Hep B / Hep C - Product Status
Table 9: PIFA Hep B / Hep C - Product Description
Table 10: PIFA PLUSS Hepatitis B Assay - Product Status
Table 11: PIFA PLUSS Hepatitis B Assay - Product Description
Table 12: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Alere i System - HBV Assay - Product Status
Table 14: Alere i System - HBV Assay - Product Description
Table 15: Alere q Analyzer - HCV VL Assay - Product Status
Table 16: Alere q Analyzer - HCV VL Assay - Product Description
Table 17: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 18: AtomoRapid - Hepatitis C - Product Status
Table 19: AtomoRapid - Hepatitis C - Product Description
Table 20: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Idylla Viral Load Assay - HBV - Product Status
Table 22: Idylla Viral Load Assay - HBV - Product Description
Table 23: Idylla Viral Load Assay - HCV - Product Status
Table 24: Idylla Viral Load Assay - HCV - Product Description
Table 25: bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 26: INSTI Test - Hepatitis B - Product Status
Table 27: INSTI Test - Hepatitis B - Product Description
Table 28: INSTI Test - Hepatitis C - Product Status
Table 29: INSTI Test - Hepatitis C - Product Description
Table 30: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Spinit Device - Hepatitis C Biomarker Assay - Product Status
Table 32: Spinit Device - Hepatitis C Biomarker Assay - Product Description
Table 33: Biotech Consortium India Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Diagnostic Kit - Hepatitis A - Product Status
Table 35: Diagnostic Kit - Hepatitis A - Product Description
Table 36: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 37: GeneXpert Omni - Xpert HCV Viral Load - Product Status
Table 38: GeneXpert Omni - Xpert HCV Viral Load - Product Description
Table 39: Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: DPP Hepatitis C Virus Assay - Product Status
Table 41: DPP Hepatitis C Virus Assay - Product Description
Table 42: Next Generation DPP HCV Assay - Product Status
Table 43: Next Generation DPP HCV Assay - Product Description
Table 44: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Diagnostic Assay - Hepatitis C - Product Status
Table 46: Diagnostic Assay - Hepatitis C - Product Description
Table 47: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Molecular Diagnostic Kit - Hepatitis B - Product Status
Table 49: Molecular Diagnostic Kit - Hepatitis B - Product Description
Table 50: Correlia Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Diagnostic Test - Hepatitis C Infection - Product Status
Table 52: Diagnostic Test - Hepatitis C Infection - Product Description
Table 53: Daktari Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Aspect - HCV-cAg Test - Product Status
Table 55: Aspect - HCV-cAg Test - Product Description
Table 56: Daktari HCV Assay - Product Status
Table 57: Daktari HCV Assay - Product Description
Table 58: Diagnostics For All Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Paper-Based Microfluidic Device - Hepatitis B - Product Status
Table 60: Paper-Based Microfluidic Device - Hepatitis B - Product Description
Table 61: Paper-Based Microfluidic Device - Hepatitis C - Product Status
Table 62: Paper-Based Microfluidic Device - Hepatitis C - Product Description
Table 63: Fast-track diagnostics S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview
Table 64: FTD HDV RNA Assay - Product Status
Table 65: FTD HDV RNA Assay - Product Description
Table 66: FTD Hepatitis B DNA Assay - Product Status
Table 67: FTD Hepatitis B DNA Assay - Product Description
Table 68: FTD Hepatitis C RNA Assay - Product Status
Table 69: FTD Hepatitis C RNA Assay - Product Description
Table 70: FTD Hepatitis E RNA Assay - Product Status
Table 71: FTD Hepatitis E RNA Assay - Product Description
Table 72: GeneBio Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: HCV Assay - Product Status
Table 74: HCV Assay - Product Description
Table 75: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Genedrive HCV ID Kit - Product Status
Table 77: Genedrive HCV ID Kit - Product Description
Table 78: Genedrive Next-Generation HCV Test - Product Status
Table 79: Genedrive Next-Generation HCV Test - Product Description
Table 80: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Multidiagnostic - Hepatitis A-D Virus Test - Product Status
Table 82: Multidiagnostic - Hepatitis A-D Virus Test - Product Description
Table 83: Multidiagnostic - Hepatitis Load Test - Product Status
Table 84: Multidiagnostic - Hepatitis Load Test - Product Description
Table 85: ImmunoScience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Salivax - Hepatitis B - Product Status
Table 87: Salivax - Hepatitis B - Product Description
Table 88: Salivax - Hepatitis C - Product Status
Table 89: Salivax - Hepatitis C - Product Description
Table 90: MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Reveal HBsAg Rapid Test - Product Status
Table 92: Reveal HBsAg Rapid Test - Product Description
Table 93: Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 94: PanNAT - HBV Assay - Product Status
Table 95: PanNAT - HBV Assay - Product Description
Table 96: PanNAT - HCV Assay - Product Status
Table 97: PanNAT - HCV Assay - Product Description
Table 98: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 99: Truenat HCV Viral Load Assay - Product Status
Table 100: Truenat HCV Viral Load Assay - Product Description
Table 101: Truenat HPV Assay - Product Status
Table 102: Truenat HPV Assay - Product Description
Table 103: NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 104: ADEXUSDx Hepatitis B Test - Product Status
Table 105: ADEXUSDx Hepatitis B Test - Product Description
Table 106: ADEXUSDx Hepatitis C Test - Product Status
Table 107: ADEXUSDx Hepatitis C Test - Product Description
Table 108: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Diagnostic Assay - HBV - Product Status
Table 110: Diagnostic Assay - HBV - Product Description
Table 111: Sedia Biosciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Asanté Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test - Product Status
Table 113: Asanté Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test - Product Description
Table 114: Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test - Product Status
Table 115: Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test - Product Description
Table 116: University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
Table 117: One-Step Screening And Diagnostic Test - HCV Infection - Product Status
Table 118: One-Step Screening And Diagnostic Test - HCV Infection - Product Description
Table 119: Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 120: EOSCAPE-CLEF - Product Status
Table 121: EOSCAPE-CLEF - Product Description
Table 122: EOSCAPE-HBV DNA - Product Status
Table 123: EOSCAPE-HBV DNA - Product Description
Table 124: EOSCAPE-HBV DNA PLUS - Product Status
Table 125: EOSCAPE-HBV DNA PLUS - Product Description
Table 126: EOSCAPE-HCV RNA - Product Status
Table 127: EOSCAPE-HCV RNA - Product Description
Table 128: Xagenic Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 129: Hepatitis C Virus Genotyping Assay - Product Status
Table 130: Hepatitis C Virus Genotyping Assay - Product Description
Table 131: Glossary

List of Figures
Figure 1: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Stage of Development
Figure 2: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Territory
Figure 3: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Regulatory Path
Figure 4: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Akers Biosciences Inc
  • Alere Inc
  • Atomo Diagnostics Pty Limited
  • Biocartis SA
  • bioLytical Laboratories Inc
  • Biosurfit, SA
  • Biotech Consortium India Ltd
  • Cepheid
  • Chembio Diagnostic Systems Inc
  • ChipCare Corp
  • Co-Diagnostics HBDC, Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll